Clinical test allows patients to be directly matched to clinical trial

By The Science Advisory Board staff writers

September 16, 2020 -- Ashion Analytics has partnered with Elevation Oncology to match patients harboring an NRG1 gene fusion identified with Ashion's Gem Extra test with a phase II clinical study of seribantumab, an investigational monoclonal antibody treatment for advanced solid tumors.

NRG1 gene fusions are a rare genomic alteration that drives tumor development and growth in many types of solid tumors including lung, breast, pancreatic, ovarian, and colorectal cancers. Crestone, a clinical trial evaluating seribantumab in tumors with NRG1 fusions sponsored by Elevation, is an investigational treatment option for patients with advanced solid tumors that have not responded to standard cancer treatments, and whose tumor has tested positive for the NRG1 fusion.

In the partnership, Ashion Analytics will leverage its technology platform to efficiently identify and directly match eligible patients to the Crestone trial using test results that are already available, namely Ashion's Gem Extra test. The test detects tumor-specific mutations in both DNA and RNA and enables physicians to make the best-available treatment recommendations for patients with advanced solid tumors.

Ashion Analytics is a clinical laboratory of the Translational Genomics Research Institute, an affiliate of City of Hope.

City of Hope sponsors COVID-19 research
City of Hope released details of multiple COVID-19 research projects, including the development of two potential vaccines, new therapies, and better screening...
Modified CRISPR system aims to improve therapies for HIV, sickle cell disease
Researchers from City of Hope have improved the CRISPR-Cas9 system through novel sequence changes to the trans-activating RNA (tracrRNA). The improved...

Copyright © 2020

Register below for our weekly Letter from the Editor to receive the latest Science news and insights.
Festival of Genomics & Biodata
January 28-29, 2021
London, Greater London United Kingdom
Lab of the Future USA
May 11-12, 2021
Boston, Massachusetts United States
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter